Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms
Jennifer Huberty, Ryan Eckert, Krisstina Gowin, Jules Mitchell, Amylou C. Dueck, Brenda Ginos, Linda Larkey, Ruben A. Mesa
Abstract
Jennifer Huberty, Ryan Eckert, Krisstina Gowin, Jules Mitchell, Amylou C. Dueck, Brenda Ginos, Linda Larkey, Ruben A. Mesa
Abstract
Myeloproliferative neoplasms (MPNs) including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) are clonal, progressive, hematological malignancies resulting in the risk of vascular events, splenomegaly, and significant symptom burden, with a high prevalence of fatigue.[
OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Myeloproliferative neoplasms (MPNs) including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) are clonal, progressive, hematological malignancies resulting in the risk of vascular events, splenomegaly, and significant symptom burden, with a high prevalence of fatigue.[
Key concepts: Essential thrombocythemia, Polycythemia vera, Myelofibrosis, Medicine, Myeloproliferative neoplasm, Myeloproliferative Disorders, Internal medicine, Ruxolitinib